Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4

Colorectal cancer is among the most lethal of malignancies, due to its propensity to metastatic spread and multifactorial-chemoresistance. The latter property supports the need to identify novel therapeutic approaches for the treatment of colorectal cancer. MicroRNAs are endogenous non-coding small...

Full description

Saved in:
Bibliographic Details
Main Authors: Reza Nedaeinia, Mohammadreza Sharifi, Amir Avan, Mohammad Kazemi, Abdolreza Nabinejad, Gordon A Ferns, Majid Ghayour-Mobarhan, Rasoul Salehi
Format: Article
Language:English
Published: SAGE Publishing 2017-03-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317692261
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839598945346519040
author Reza Nedaeinia
Mohammadreza Sharifi
Amir Avan
Mohammad Kazemi
Abdolreza Nabinejad
Gordon A Ferns
Majid Ghayour-Mobarhan
Rasoul Salehi
author_facet Reza Nedaeinia
Mohammadreza Sharifi
Amir Avan
Mohammad Kazemi
Abdolreza Nabinejad
Gordon A Ferns
Majid Ghayour-Mobarhan
Rasoul Salehi
author_sort Reza Nedaeinia
collection DOAJ
description Colorectal cancer is among the most lethal of malignancies, due to its propensity to metastatic spread and multifactorial-chemoresistance. The latter property supports the need to identify novel therapeutic approaches for the treatment of colorectal cancer. MicroRNAs are endogenous non-coding small RNA molecules that function as post-transcriptional regulators of gene expression. Recently, programmed cell death 4 has been identified as a protein that increases during apoptosis. This gene is among the potential targets of miR-21 (OncomiR). Locked nucleic acid–modified oligonucleotides have recently emerged as a potential therapeutic option for targeting microRNAs. The aim of this study was to explore the functional role of locked nucleic acid-anti-miR-21 in the LS174T cell line in vitro and in vivo models. LS174T cells were treated with locked nucleic acid-anti-miR-21 for 24, 48, and 72 h in vitro. The expression of miR-21 and PDCD4 at messenger RNA (mRNA) level was evaluated by quantitative real-time polymerase chain reaction, while the protein level of PDCD4 was determined by Western blotting. Cell migratory behavior and the cluster-forming ability of cells were assessed before and after therapy. The disseminated tumor cells were assessed in the chick chorioallantoic membrane model by Alu quantitative polymerase chain reaction. Locked nucleic acid-anti-miR-21 was transfected successfully into the LS174T cells and inhibited the expression of miR-21. Locked nucleic acid-anti-miR-21 inhibited the migration and the number of cells forming clusters. Moreover, we found that locked nucleic acid-anti-miR-21 transfection was associated with a significant reduction in metastatic properties as assessed by the in ovo model. Our findings demonstrated the novel therapeutic potential of locked nucleic acid-anti-miR-21 in colon adenocarcinoma with high miR-21 expression.
format Article
id doaj-art-a3ee1a4cf4ec4ba7b3c17de9cefb51a8
institution Matheson Library
issn 1423-0380
language English
publishDate 2017-03-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-a3ee1a4cf4ec4ba7b3c17de9cefb51a82025-08-02T15:43:10ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317692261Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4Reza Nedaeinia0Mohammadreza Sharifi1Amir Avan2Mohammad Kazemi3Abdolreza Nabinejad4Gordon A Ferns5Majid Ghayour-Mobarhan6Rasoul Salehi7Students Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranMolecular Medicine Group, Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranIsfahan Research Center for Agriculture and Natural Resources, Isfahan, IranDivision of Medical Education, Brighton and Sussex Medical School, University of Brighton, Brighton, UKBiochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IranGerfa Namayesh Azmayesh (GENAZMA) Science and Research Institute, Isfahan, IranColorectal cancer is among the most lethal of malignancies, due to its propensity to metastatic spread and multifactorial-chemoresistance. The latter property supports the need to identify novel therapeutic approaches for the treatment of colorectal cancer. MicroRNAs are endogenous non-coding small RNA molecules that function as post-transcriptional regulators of gene expression. Recently, programmed cell death 4 has been identified as a protein that increases during apoptosis. This gene is among the potential targets of miR-21 (OncomiR). Locked nucleic acid–modified oligonucleotides have recently emerged as a potential therapeutic option for targeting microRNAs. The aim of this study was to explore the functional role of locked nucleic acid-anti-miR-21 in the LS174T cell line in vitro and in vivo models. LS174T cells were treated with locked nucleic acid-anti-miR-21 for 24, 48, and 72 h in vitro. The expression of miR-21 and PDCD4 at messenger RNA (mRNA) level was evaluated by quantitative real-time polymerase chain reaction, while the protein level of PDCD4 was determined by Western blotting. Cell migratory behavior and the cluster-forming ability of cells were assessed before and after therapy. The disseminated tumor cells were assessed in the chick chorioallantoic membrane model by Alu quantitative polymerase chain reaction. Locked nucleic acid-anti-miR-21 was transfected successfully into the LS174T cells and inhibited the expression of miR-21. Locked nucleic acid-anti-miR-21 inhibited the migration and the number of cells forming clusters. Moreover, we found that locked nucleic acid-anti-miR-21 transfection was associated with a significant reduction in metastatic properties as assessed by the in ovo model. Our findings demonstrated the novel therapeutic potential of locked nucleic acid-anti-miR-21 in colon adenocarcinoma with high miR-21 expression.https://doi.org/10.1177/1010428317692261
spellingShingle Reza Nedaeinia
Mohammadreza Sharifi
Amir Avan
Mohammad Kazemi
Abdolreza Nabinejad
Gordon A Ferns
Majid Ghayour-Mobarhan
Rasoul Salehi
Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
Tumor Biology
title Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
title_full Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
title_fullStr Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
title_full_unstemmed Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
title_short Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
title_sort inhibition of microrna 21 via locked nucleic acid anti mir suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4
url https://doi.org/10.1177/1010428317692261
work_keys_str_mv AT rezanedaeinia inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT mohammadrezasharifi inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT amiravan inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT mohammadkazemi inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT abdolrezanabinejad inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT gordonaferns inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT majidghayourmobarhan inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4
AT rasoulsalehi inhibitionofmicrorna21vialockednucleicacidantimirsuppressedmetastaticfeaturesofcolorectalcancercellsthroughmodulationofprogrammedcelldeath4